The emergence of Monkeypox Virus: its complications, connection with smallpox and its future aspects - a short review
https://doi.org/10.4081/idhm.2024.388
Accepted: 18 June 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Monkeypox Virus (MPXV), a zoonotic orthopox DNA virus related to the smallpox virus, was first identified in humans in 1970. The World Health Organization (WHO) declared monkeypox an "evolving hazard of moderate public health concern" on 23 June 2022. Case reports included in this study showed that all patients with typical rashes and risky sexual behaviour should be encouraged to seek immediate medical attention. If a patient has had sexual contact, a diagnosis of monkeypox should be considered even if the patient does not travel to other countries. According to authentic proof from Africa, smallpox immunization is at least 85% successful at avoiding monkeypox. Given the inadequate health infrastructure in Low and Middle-Income Countries (LMIC), it would be extremely challenging to implement vaccination as a regular component of immunization programs. Patients with monkeypox may experience complications, including bacterial superinfection, encephalitis, pneumonia, and conjunctivitis/keratitis. Seldom-recorded complications incorporate bronchopneumonia, spewing, and corneal scarring, leading to lasting visual deficiency. Lowering the risk of transmission from person to person, reducing the risk of zoonotic transmission, preventing monkeypox by limiting the trade in animals, engaging the LGBTQIA community, and vaccination may reduce and control monkeypox.
Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022;387:679-91.
Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox - A potential threat? A systematic review. PLoS Negl Trop Dis 2022;16:e0010141.
Kampf G. Efficacy of biocidal agents and disinfectants against the Monkeypox Virus and other orthopoxviruses. Journal of Hospital Infection. 2022;127:101-10.
Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011;29:D54-9.
Lachyan AS, Khan AM, Zaki RA, Banerjee B. Effect of community-based intervention on awareness of dengue and its prevention among urban poor community in India – a systematic review approach. Int J Community Med Public Health 2020;7:5182-9.
Lachyan AS, Fui WM, Banerjee B, Zaki RA. Situational analysis: gerontechnology and older persons wellbeing in developing countries. International Journal of Medical and Pharmaceutical Research. 2020;1:7694307.
World Health Organization (WHO). Monkeypox. 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox
Oprea C, Ianache I, Piscu S, et al. First report of monkeypox in a patient living with HIV from Romania. Travel medicine and infectious disease. 2022;49:102395.
BBC. Monkeypox: London sees rise in cases in last month. Available from: https://www.bbc.com/news/uk-65713682
Kabuga AI, El Zowalaty ME. A review of the Monkeypox Virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol. 2019;91:533-40.
Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742-51.
Cash-Goldwasser S, Labuda SM, McCormick DW, et al. Ocular monkeypox - United States, July-September 2022. MMWR Morb Mortal Wkly Rep 2022;71:1343.
Titanji BK, Tegomoh B, Nematollahi S, et al. Monkeypox: a contemporary review for healthcare professionals. Open Forum Infect Dis. 2022;9:ofac310.
Rimoin AW, Mulembakani PM, Johnston SC, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci. 2010;107:16262-7.
US Centers for Disease Control. Monkeypox and smallpox vaccine guidance. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html
Nguyen PY, Ajisegiri WS, Costantino V, et al. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020. Emerg Infect Dis. 2021;27:1007-14.
The Atlantic. The future of monkeypox. 2022. Available from: https://www.theatlantic.com/health/archive/2022/11/monkeypox-mpox-cases-us-outbreak/672277/
Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156:293‐8.
Girometti N, Byrne R, Bracchi M, et al. Demographic and clinical characteristics of confirmed human Monkeypox Virus cases in individuals attending a sexual health center in London, UK: an observational analysis. Lancet Infect Dis. 2022;22:1321-8.
Hirani R, Noruzi K, Iqbal A, et al. A review of the past, present, and future of the Monkeypox Virus: challenges, opportunities, and lessons from COVID-19 for global health security. Microorganisms. 2023;11:2713.
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
